Type 1 Diabetes Management Flashcards
What is the total daily insulin dose per kg/day for Type 1
0.5 units/kg/day
or 0.3-1 units/kg
What is the MOA of basal insulin in normal people
Secreted in small amounts during sleep or long-fasting hours
- suppresses gluconeogenesis + lipolysis
Describe the 2 phases of bolus insulin in normal people
Phase 1
- release of pre-formed insulin within 1 min of glucose consumption and lasts about 10 min
Phase 2:
- synthesis and release of newly formed insulin
- released until normoglycemic state restored
Who are premixed insulins for?
Someone with set meal/exercise times (nursing home)
What is the longest acting insulin? What is the benefit of it?
Degludec (tresiba)
- causes less nocturnal hypos
What is the benefit of Humalog U-200?
For patients requiring 20+ units of rapid insulin
(double the unit per pen)
What is the benefit of using entuzity U-500?
- For patients requiring 200+ units of rapid insulin
- delivers dose in 5 unit increments
Differentiate between endogenous and exogenous insulin absorption
Endogenous insulin is secreted into portal vein
- undergoes first-pass metabolism
- released in small bursts in response to glucose
Exogenous
- higher peripheral exposure than hepatic
- release is pre-determined via a time-action profile
What are benefits of insulin therapy?
- delay microvascular (retinopaty, nephropathy, neuropathy) and CV complications
- prevent ketoacidosis
- prevent overt hyperglycemia symptoms
What are adverse effects of insulin
Hypoglycemia: more common with regular insulin than rapid-acting insulin
Weight gain: ~4-5kg
Allergic reactions: 0.1-3% (rare)
Lipohypertrophy: 49-64% prevalence
Is there evidence for adjunctive therapy in type 1 diabetic patients?
No
Metformin: did not provide sustained metabolic or CV benefits
SGLT2 inhibitors: some metabolic benefits, risk of DKA needs more study
Liraglutide: some metabolic benefits, NO indication for use in T1DM
What is the preferred insulin injection site?
Abdomen
When would you consider using an insulin pump in T1DM
- Not able to reach targets despite optimized basal-bolus regimen
- sig glucose variability
- frequent severe hypoglycemia or hypoglycemic unawareness
- Sig dawn phenomenon: release of GH and cortisol is early morning stimulates glucose release
- Low insulin requirements
- suboptimal treatment satisfaction and quality of life
- women contemplating pregnancy
What factors influence insulin action?
- Route of admin (IV > IM > SC)
- Renal function (lowers clearance, intensifies action)
- insulin antibodies (delays effect)
- Thyroid function
- Site of injection (stomach fastest, arm intermediate, thigh slowest)
- Exercise, massaging inj site, higher temp (faster absorption)
- insulin prep (cloudy -> gently rolled or tipped)
- insulin dose and concentration
- Lipohypertrophy (delay absorption)
Differentiate between conventional and intensive insulin therapy in T1DM
Conventional (not preferred)
- Use of premixed or self-mixed int and short or rapid acting insulin
- BID injections
- Fixed amount of insulin and consistent food and activity
Intensive therapy
- system of matching insulin doses to food, activity, and life events
- basal-bolus insulin injections or pumps
- requires patient self-management behaviours